Request for Covid-19 Impact Assessment of this Report
The United States Valganciclovir market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Valganciclovir market, reaching US$ million by the year 2028. As for the Europe Valganciclovir landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Valganciclovir players cover Rakshit Drugs, United Biotech Private Limited, Roche, and , etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Valganciclovir market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Powder
Tablet
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Adults
Children
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Rakshit Drugs
United Biotech Private Limited
Roche
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Valganciclovir Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Valganciclovir by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Valganciclovir by Country/Region, 2017, 2022 & 2028
2.2 Valganciclovir Segment by Type
2.2.1 Powder
2.2.2 Tablet
2.3 Valganciclovir Sales by Type
2.3.1 Global Valganciclovir Sales Market Share by Type (2017-2022)
2.3.2 Global Valganciclovir Revenue and Market Share by Type (2017-2022)
2.3.3 Global Valganciclovir Sale Price by Type (2017-2022)
2.4 Valganciclovir Segment by Application
2.4.1 Adults
2.4.2 Children
2.5 Valganciclovir Sales by Application
2.5.1 Global Valganciclovir Sale Market Share by Application (2017-2022)
2.5.2 Global Valganciclovir Revenue and Market Share by Application (2017-2022)
2.5.3 Global Valganciclovir Sale Price by Application (2017-2022)
3 Global Valganciclovir by Company
3.1 Global Valganciclovir Breakdown Data by Company
3.1.1 Global Valganciclovir Annual Sales by Company (2020-2022)
3.1.2 Global Valganciclovir Sales Market Share by Company (2020-2022)
3.2 Global Valganciclovir Annual Revenue by Company (2020-2022)
3.2.1 Global Valganciclovir Revenue by Company (2020-2022)
3.2.2 Global Valganciclovir Revenue Market Share by Company (2020-2022)
3.3 Global Valganciclovir Sale Price by Company
3.4 Key Manufacturers Valganciclovir Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Valganciclovir Product Location Distribution
3.4.2 Players Valganciclovir Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Valganciclovir by Geographic Region
4.1 World Historic Valganciclovir Market Size by Geographic Region (2017-2022)
4.1.1 Global Valganciclovir Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Valganciclovir Annual Revenue by Geographic Region
4.2 World Historic Valganciclovir Market Size by Country/Region (2017-2022)
4.2.1 Global Valganciclovir Annual Sales by Country/Region (2017-2022)
4.2.2 Global Valganciclovir Annual Revenue by Country/Region
4.3 Americas Valganciclovir Sales Growth
4.4 APAC Valganciclovir Sales Growth
4.5 Europe Valganciclovir Sales Growth
4.6 Middle East & Africa Valganciclovir Sales Growth
5 Americas
5.1 Americas Valganciclovir Sales by Country
5.1.1 Americas Valganciclovir Sales by Country (2017-2022)
5.1.2 Americas Valganciclovir Revenue by Country (2017-2022)
5.2 Americas Valganciclovir Sales by Type
5.3 Americas Valganciclovir Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Valganciclovir Sales by Region
6.1.1 APAC Valganciclovir Sales by Region (2017-2022)
6.1.2 APAC Valganciclovir Revenue by Region (2017-2022)
6.2 APAC Valganciclovir Sales by Type
6.3 APAC Valganciclovir Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Valganciclovir by Country
7.1.1 Europe Valganciclovir Sales by Country (2017-2022)
7.1.2 Europe Valganciclovir Revenue by Country (2017-2022)
7.2 Europe Valganciclovir Sales by Type
7.3 Europe Valganciclovir Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Valganciclovir by Country
8.1.1 Middle East & Africa Valganciclovir Sales by Country (2017-2022)
8.1.2 Middle East & Africa Valganciclovir Revenue by Country (2017-2022)
8.2 Middle East & Africa Valganciclovir Sales by Type
8.3 Middle East & Africa Valganciclovir Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Valganciclovir
10.3 Manufacturing Process Analysis of Valganciclovir
10.4 Industry Chain Structure of Valganciclovir
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Valganciclovir Distributors
11.3 Valganciclovir Customer
12 World Forecast Review for Valganciclovir by Geographic Region
12.1 Global Valganciclovir Market Size Forecast by Region
12.1.1 Global Valganciclovir Forecast by Region (2023-2028)
12.1.2 Global Valganciclovir Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Valganciclovir Forecast by Type
12.7 Global Valganciclovir Forecast by Application
13 Key Players Analysis
13.1 Rakshit Drugs
13.1.1 Rakshit Drugs Company Information
13.1.2 Rakshit Drugs Valganciclovir Product Offered
13.1.3 Rakshit Drugs Valganciclovir Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Rakshit Drugs Main Business Overview
13.1.5 Rakshit Drugs Latest Developments
13.2 United Biotech Private Limited
13.2.1 United Biotech Private Limited Company Information
13.2.2 United Biotech Private Limited Valganciclovir Product Offered
13.2.3 United Biotech Private Limited Valganciclovir Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 United Biotech Private Limited Main Business Overview
13.2.5 United Biotech Private Limited Latest Developments
13.3 Roche
13.3.1 Roche Company Information
13.3.2 Roche Valganciclovir Product Offered
13.3.3 Roche Valganciclovir Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Roche Main Business Overview
13.3.5 Roche Latest Developments
14 Research Findings and Conclusion
Table 1. Valganciclovir Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Valganciclovir Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Powder
Table 4. Major Players of Tablet
Table 5. Global Valganciclovir Sales by Type (2017-2022) & (K Units)
Table 6. Global Valganciclovir Sales Market Share by Type (2017-2022)
Table 7. Global Valganciclovir Revenue by Type (2017-2022) & ($ million)
Table 8. Global Valganciclovir Revenue Market Share by Type (2017-2022)
Table 9. Global Valganciclovir Sale Price by Type (2017-2022) & (USD/Unit)
Table 10. Global Valganciclovir Sales by Application (2017-2022) & (K Units)
Table 11. Global Valganciclovir Sales Market Share by Application (2017-2022)
Table 12. Global Valganciclovir Revenue by Application (2017-2022)
Table 13. Global Valganciclovir Revenue Market Share by Application (2017-2022)
Table 14. Global Valganciclovir Sale Price by Application (2017-2022) & (USD/Unit)
Table 15. Global Valganciclovir Sales by Company (2020-2022) & (K Units)
Table 16. Global Valganciclovir Sales Market Share by Company (2020-2022)
Table 17. Global Valganciclovir Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Valganciclovir Revenue Market Share by Company (2020-2022)
Table 19. Global Valganciclovir Sale Price by Company (2020-2022) & (USD/Unit)
Table 20. Key Manufacturers Valganciclovir Producing Area Distribution and Sales Area
Table 21. Players Valganciclovir Products Offered
Table 22. Valganciclovir Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Valganciclovir Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Valganciclovir Sales Market Share Geographic Region (2017-2022)
Table 27. Global Valganciclovir Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Valganciclovir Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Valganciclovir Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Valganciclovir Sales Market Share by Country/Region (2017-2022)
Table 31. Global Valganciclovir Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Valganciclovir Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Valganciclovir Sales by Country (2017-2022) & (K Units)
Table 34. Americas Valganciclovir Sales Market Share by Country (2017-2022)
Table 35. Americas Valganciclovir Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Valganciclovir Revenue Market Share by Country (2017-2022)
Table 37. Americas Valganciclovir Sales by Type (2017-2022) & (K Units)
Table 38. Americas Valganciclovir Sales Market Share by Type (2017-2022)
Table 39. Americas Valganciclovir Sales by Application (2017-2022) & (K Units)
Table 40. Americas Valganciclovir Sales Market Share by Application (2017-2022)
Table 41. APAC Valganciclovir Sales by Region (2017-2022) & (K Units)
Table 42. APAC Valganciclovir Sales Market Share by Region (2017-2022)
Table 43. APAC Valganciclovir Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Valganciclovir Revenue Market Share by Region (2017-2022)
Table 45. APAC Valganciclovir Sales by Type (2017-2022) & (K Units)
Table 46. APAC Valganciclovir Sales Market Share by Type (2017-2022)
Table 47. APAC Valganciclovir Sales by Application (2017-2022) & (K Units)
Table 48. APAC Valganciclovir Sales Market Share by Application (2017-2022)
Table 49. Europe Valganciclovir Sales by Country (2017-2022) & (K Units)
Table 50. Europe Valganciclovir Sales Market Share by Country (2017-2022)
Table 51. Europe Valganciclovir Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Valganciclovir Revenue Market Share by Country (2017-2022)
Table 53. Europe Valganciclovir Sales by Type (2017-2022) & (K Units)
Table 54. Europe Valganciclovir Sales Market Share by Type (2017-2022)
Table 55. Europe Valganciclovir Sales by Application (2017-2022) & (K Units)
Table 56. Europe Valganciclovir Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Valganciclovir Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Valganciclovir Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Valganciclovir Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Valganciclovir Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Valganciclovir Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Valganciclovir Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Valganciclovir Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Valganciclovir Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Valganciclovir
Table 66. Key Market Challenges & Risks of Valganciclovir
Table 67. Key Industry Trends of Valganciclovir
Table 68. Valganciclovir Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Valganciclovir Distributors List
Table 71. Valganciclovir Customer List
Table 72. Global Valganciclovir Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Valganciclovir Sales Market Forecast by Region
Table 74. Global Valganciclovir Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Valganciclovir Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Valganciclovir Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Valganciclovir Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Valganciclovir Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Valganciclovir Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Valganciclovir Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Valganciclovir Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Valganciclovir Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Valganciclovir Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Valganciclovir Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Valganciclovir Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Valganciclovir Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Valganciclovir Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Valganciclovir Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Valganciclovir Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Valganciclovir Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Valganciclovir Revenue Market Share Forecast by Application (2023-2028)
Table 92. Rakshit Drugs Basic Information, Valganciclovir Manufacturing Base, Sales Area and Its Competitors
Table 93. Rakshit Drugs Valganciclovir Product Offered
Table 94. Rakshit Drugs Valganciclovir Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 95. Rakshit Drugs Main Business
Table 96. Rakshit Drugs Latest Developments
Table 97. United Biotech Private Limited Basic Information, Valganciclovir Manufacturing Base, Sales Area and Its Competitors
Table 98. United Biotech Private Limited Valganciclovir Product Offered
Table 99. United Biotech Private Limited Valganciclovir Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 100. United Biotech Private Limited Main Business
Table 101. United Biotech Private Limited Latest Developments
Table 102. Roche Basic Information, Valganciclovir Manufacturing Base, Sales Area and Its Competitors
Table 103. Roche Valganciclovir Product Offered
Table 104. Roche Valganciclovir Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 105. Roche Main Business
Table 106. Roche Latest Developments
List of Figures
Figure 1. Picture of Valganciclovir
Figure 2. Valganciclovir Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Valganciclovir Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Valganciclovir Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Valganciclovir Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Powder
Figure 10. Product Picture of Tablet
Figure 11. Global Valganciclovir Sales Market Share by Type in 2021
Figure 12. Global Valganciclovir Revenue Market Share by Type (2017-2022)
Figure 13. Valganciclovir Consumed in Adults
Figure 14. Global Valganciclovir Market: Adults (2017-2022) & (K Units)
Figure 15. Valganciclovir Consumed in Children
Figure 16. Global Valganciclovir Market: Children (2017-2022) & (K Units)
Figure 17. Global Valganciclovir Sales Market Share by Application (2017-2022)
Figure 18. Global Valganciclovir Revenue Market Share by Application in 2021
Figure 19. Valganciclovir Revenue Market by Company in 2021 ($ Million)
Figure 20. Global Valganciclovir Revenue Market Share by Company in 2021
Figure 21. Global Valganciclovir Sales Market Share by Geographic Region (2017-2022)
Figure 22. Global Valganciclovir Revenue Market Share by Geographic Region in 2021
Figure 23. Global Valganciclovir Sales Market Share by Region (2017-2022)
Figure 24. Global Valganciclovir Revenue Market Share by Country/Region in 2021
Figure 25. Americas Valganciclovir Sales 2017-2022 (K Units)
Figure 26. Americas Valganciclovir Revenue 2017-2022 ($ Millions)
Figure 27. APAC Valganciclovir Sales 2017-2022 (K Units)
Figure 28. APAC Valganciclovir Revenue 2017-2022 ($ Millions)
Figure 29. Europe Valganciclovir Sales 2017-2022 (K Units)
Figure 30. Europe Valganciclovir Revenue 2017-2022 ($ Millions)
Figure 31. Middle East & Africa Valganciclovir Sales 2017-2022 (K Units)
Figure 32. Middle East & Africa Valganciclovir Revenue 2017-2022 ($ Millions)
Figure 33. Americas Valganciclovir Sales Market Share by Country in 2021
Figure 34. Americas Valganciclovir Revenue Market Share by Country in 2021
Figure 35. United States Valganciclovir Revenue Growth 2017-2022 ($ Millions)
Figure 36. Canada Valganciclovir Revenue Growth 2017-2022 ($ Millions)
Figure 37. Mexico Valganciclovir Revenue Growth 2017-2022 ($ Millions)
Figure 38. Brazil Valganciclovir Revenue Growth 2017-2022 ($ Millions)
Figure 39. APAC Valganciclovir Sales Market Share by Region in 2021
Figure 40. APAC Valganciclovir Revenue Market Share by Regions in 2021
Figure 41. China Valganciclovir Revenue Growth 2017-2022 ($ Millions)
Figure 42. Japan Valganciclovir Revenue Growth 2017-2022 ($ Millions)
Figure 43. South Korea Valganciclovir Revenue Growth 2017-2022 ($ Millions)
Figure 44. Southeast Asia Valganciclovir Revenue Growth 2017-2022 ($ Millions)
Figure 45. India Valganciclovir Revenue Growth 2017-2022 ($ Millions)
Figure 46. Australia Valganciclovir Revenue Growth 2017-2022 ($ Millions)
Figure 47. Europe Valganciclovir Sales Market Share by Country in 2021
Figure 48. Europe Valganciclovir Revenue Market Share by Country in 2021
Figure 49. Germany Valganciclovir Revenue Growth 2017-2022 ($ Millions)
Figure 50. France Valganciclovir Revenue Growth 2017-2022 ($ Millions)
Figure 51. UK Valganciclovir Revenue Growth 2017-2022 ($ Millions)
Figure 52. Italy Valganciclovir Revenue Growth 2017-2022 ($ Millions)
Figure 53. Russia Valganciclovir Revenue Growth 2017-2022 ($ Millions)
Figure 54. Middle East & Africa Valganciclovir Sales Market Share by Country in 2021
Figure 55. Middle East & Africa Valganciclovir Revenue Market Share by Country in 2021
Figure 56. Egypt Valganciclovir Revenue Growth 2017-2022 ($ Millions)
Figure 57. South Africa Valganciclovir Revenue Growth 2017-2022 ($ Millions)
Figure 58. Israel Valganciclovir Revenue Growth 2017-2022 ($ Millions)
Figure 59. Turkey Valganciclovir Revenue Growth 2017-2022 ($ Millions)
Figure 60. GCC Country Valganciclovir Revenue Growth 2017-2022 ($ Millions)
Figure 61. Manufacturing Cost Structure Analysis of Valganciclovir in 2021
Figure 62. Manufacturing Process Analysis of Valganciclovir
Figure 63. Industry Chain Structure of Valganciclovir
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...